Experiences with Next-Generation Sequencing in Relapsed Acute Myeloid Leukemia: A Patient Case Series.
作者信息
Flach Johanna, Shumilov Evgenii, Porret Naomi, Shakhanova Inna, Legros Myriam, Kronig Marie-Noëlle, Joncourt Raphael, Bacher Ulrike, Pabst Thomas
机构信息
Department of Hematology and Oncology, Medical Faculty Mannheim of the Heidelberg University, Mannheim, Germany.
Department of Hematology and Medical Oncology, University Medicine Göttingen (UMG), Göttingen, Germany.
出版信息
Mediterr J Hematol Infect Dis. 2020 Sep 1;12(1):e2020068. doi: 10.4084/MJHID.2020.068. eCollection 2020.
Abstract
摘要
相似文献
1
Experiences with Next-Generation Sequencing in Relapsed Acute Myeloid Leukemia: A Patient Case Series.
Mediterr J Hematol Infect Dis. 2020 Sep 1;12(1):e2020068. doi: 10.4084/MJHID.2020.068. eCollection 2020.
2
Next-generation sequencing-defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse.
Am J Hematol. 2019 Aug;94(8):902-912. doi: 10.1002/ajh.25514. Epub 2019 Jun 14.
3
Panel-based next-generation sequencing facilitates the characterization of childhood acute myeloid leukemia in clinical settings.
Biomed Rep. 2020 Nov;13(5):46. doi: 10.3892/br.2020.1353. Epub 2020 Aug 28.
4
Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms.
Cancers (Basel). 2019 Sep 13;11(9):1364. doi: 10.3390/cancers11091364.
5
Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia.
Front Pharmacol. 2017 Dec 7;8:897. doi: 10.3389/fphar.2017.00897. eCollection 2017.
6
Genetic Landscape of Acute Myeloid Leukemia Interrogated by Next-generation Sequencing: A Large Cancer Center Experience.
Cancer Genomics Proteomics. 2018 Mar-Apr;15(2):121-126. doi: 10.21873/cgp.20070.
7
Next generation sequencing of acute myeloid leukemia: influencing prognosis.
BMC Genomics. 2015;16 Suppl 1(Suppl 1):S5. doi: 10.1186/1471-2164-16-S1-S5. Epub 2015 Jan 15.
8
The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.
Int J Lab Hematol. 2015 May;37 Suppl 1:115-21. doi: 10.1111/ijlh.12361.
9
Sequencing-Based Measurable Residual Disease Testing in Acute Myeloid Leukemia.
Front Cell Dev Biol. 2020 May 8;8:249. doi: 10.3389/fcell.2020.00249. eCollection 2020.
10
Detection of Novel t(12;17)(p12;p13) in Relapsed Refractory Acute Myeloid Leukemia by Anchored Multiplex PCR(AMP)-based Next-Generation Sequencing.
Appl Immunohistochem Mol Morphol. 2019 Mar;27(3):e28-e31. doi: 10.1097/PAI.0000000000000477.
引用本文的文献
1
Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation.
Bone Marrow Transplant. 2022 Feb;57(2):224-231. doi: 10.1038/s41409-021-01521-5. Epub 2021 Nov 13.
本文引用的文献
1
Clinical potential of introducing next-generation sequencing in patients at relapse of acute myeloid leukemia.
Hematol Oncol. 2020 Oct;38(4):425-431. doi: 10.1002/hon.2739. Epub 2020 May 6.
2
Gilteritinib or Chemotherapy for Relapsed or Refractory -Mutated AML.
N Engl J Med. 2019 Oct 31;381(18):1728-1740. doi: 10.1056/NEJMoa1902688.
3
Clinical value of molecular MRD monitoring by next-generation sequencing in patients with mutated AML.
Leuk Lymphoma. 2019 Oct;60(10):2588-2590. doi: 10.1080/10428194.2019.1585838. Epub 2019 Apr 18.
4
FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation.
Clin Cancer Res. 2019 Jun 1;25(11):3205-3209. doi: 10.1158/1078-0432.CCR-18-3749. Epub 2019 Jan 28.
5
Pitfalls in the molecular follow up of mutant acute myeloid leukemia.
Haematologica. 2018 Oct;103(10):e486-e488. doi: 10.3324/haematol.2018.192104. Epub 2018 Jun 14.
6
Evolution of Cytogenetically Normal Acute Myeloid Leukemia During Therapy and Relapse: An Exome Sequencing Study of 50 Patients.
Clin Cancer Res. 2018 Apr 1;24(7):1716-1726. doi: 10.1158/1078-0432.CCR-17-2344. Epub 2018 Jan 12.
7
Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia.
Blood Adv. 2016 Dec 14;1(3):193-204. doi: 10.1182/bloodadvances.2016000760. eCollection 2016 Dec 27.
8
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.
N Engl J Med. 2017 Aug 3;377(5):454-464. doi: 10.1056/NEJMoa1614359. Epub 2017 Jun 23.
9
Enasidenib in mutant relapsed or refractory acute myeloid leukemia.
Blood. 2017 Aug 10;130(6):722-731. doi: 10.1182/blood-2017-04-779405. Epub 2017 Jun 6.
10
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
Blood. 2017 Jan 26;129(4):424-447. doi: 10.1182/blood-2016-08-733196. Epub 2016 Nov 28.
Zotero 插件